Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis vaccines: recent advances.

Raymond S Koff1

  • 1Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA. ray.koff@roche.com

International Journal for Parasitology
|June 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Direct Antiviral Agents Eliminate the Age Barrier to Treatment of Chronic Hepatitis C.

The American journal of gastroenterology·2017
Same author

Secrets of Lecturing: How I Learned to Talk the Talk.

Digestive diseases and sciences·2016
Same author

Profiles: Raymond S. Koff, MD.

Digestive diseases and sciences·2016
Same author

Cirrhosis: A Practical Guide to Management.

Gastroenterology·2015
Same author

Fundamentals of lung auscultation.

The New England journal of medicine·2014
Same author

Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases.

American journal of therapeutics·2012
Same journal

Clonal amplification and weak genetic structuring in the rumen fluke Calicophoron daubneyi at a regional scale in the French Pyrenees.

International journal for parasitology·2026
Same journal

Hidden digenean diversity in two African protected areas: metabarcoding as a tool for parasite identification.

International journal for parasitology·2026
Same journal

Nearly Bitten, Twice Shy: Effects of prior and current parasite exposure on host mating behaviour.

International journal for parasitology·2026
Same journal

Bringing order to chaos: A new classification of avian schistosomes and their genetic lineages in the context of swimmer's itch.

International journal for parasitology·2026
Same journal

Assessing myxozoan diversity in fish: microscopy-based detection versus high-throughput amplicon sequencing.

International journal for parasitology·2026
Same journal

Spatial expression analysis and target prediction give insight into microRNA function in the model cestode Hymenolepis microstoma.

International journal for parasitology·2026
See all related articles

Hepatitis A and B infections persist despite available vaccines. Universal pediatric immunization with combined vaccines and improved hepatitis B strategies could lead to eradication, while hepatitis C vaccine development faces challenges but shows promise.

Area of Science:

  • Hepatology
  • Vaccinology
  • Infectious Diseases

Background:

  • Hepatitis A and B infections remain a global health concern despite existing vaccines.
  • Current vaccination policies, particularly for Hepatitis A, are often limited to high-risk groups, hindering widespread impact.
  • The development of effective vaccines for Hepatitis C has been significantly hampered by viral diversity and research challenges.

Purpose of the Study:

  • To review the current status and future prospects of vaccines against hepatitis A, B, C, and E.
  • To highlight the potential of universal pediatric immunization for hepatitis A and B eradication.
  • To discuss the challenges and advancements in developing a hepatitis C vaccine.

Main Methods:

  • Review of existing literature on hepatitis vaccine development and efficacy.

Related Experiment Videos

  • Analysis of current vaccination strategies and their limitations.
  • Discussion of emerging technologies and ongoing research in vaccinology.

    • Main Results:

    • Combined hepatitis A and B vaccines, with improved dosing and infant immunogenicity, offer a path to eradication.
    • Hepatitis B vaccines are crucial for controlling infection in newborns and high-risk groups, potentially preventing hepatitis D.
    • Hepatitis E vaccine development is progressing with a recombinant candidate in clinical trials, while hepatitis C vaccine research faces significant hurdles but shows potential with new technologies.

    Conclusions:

    • Universal pediatric immunization with combined hepatitis A and B vaccines is a promising strategy for disease eradication.
    • Continued research into novel hepatitis vaccines, including DNA-based and plant-expressed antigens, is essential.
    • Overcoming the challenges in hepatitis C vaccine development is critical for global public health.